|Back to article|
Nuchal translucency test
Nuchal translucency is the thickness at the back of an unborn baby's neck. Measuring this thickness helps assess the risk of Down syndrome.
How the Test Is Performed
Your health care provider will use ultrasound to measure the thickness at the back of the baby's neck. All babies have some fluid at the back of their neck, but in Down syndrome there is more fluid than normal. This makes the space look thicker.
A blood test of the mother is also done. Together, these two tests will tell if the baby could have Down syndrome.
How to Prepare for the Test
Having a full bladder will give the best ultrasound picture. You may be asked to drink two to three glasses of liquid an hour before the test. Do not urinate before your ultrasound.
How the Test Will Feel
You may have some discomfort from pressure on your bladder during the ultrasound. The gel on the ultrasound wand may feel slightly cold and wet. You will not feel the ultrasound waves.
Why the test is performed
Your health care provider may recommend this test to screen your baby for Down syndrome. Many pregnant women decide to have this test.
This test can be done earlier in pregnancy than amniocentesis (another test that checks for birth defects). Nuchal translucency is usually done between 11 and 14 weeks of pregnancy.
A nuchal pregnancy test detects only Down syndrome. It does not detect neural tube defects or other birth defects.
A normal amount of fluid in the back of the neck during ultrasound means that it is very unlikely your baby has Down syndrome.
What abnormal results mean
More fluid than normal in the back of the neck means there is a greater risk of Down syndrome. However, it does not tell for certain that the baby has Down syndrome.
If the result is abnormal, other testing can be done. Most of the time, the other test done is amniocentesis.
What the risks are
There are no known risks from ultrasound. Ultrasound does not involve radiation, like x-rays do.
Simpson JL, Holzgreve W, Driscoll DA. Genetic counseling and genetic screening. In: Gabbe SG, Niebyl JR, Simpson JL, et al, eds. Obstetrics: Normal and Problem Pregnancies. 6th ed. Philadelphia, Pa: Saunders Elsevier; 2012:chap 10.
Reviewed by:Susan Storck, MD, FACOG, Chief, Eastside Department of Obstetrics and Gynecology, Group Health Cooperative of Puget Sound, Bellevue, Washington; Clinical Teaching Faculty, Deaprtment of Obstetrics and Gynecology, University of Washington School of Medicine. Also reviewed by David Zieve, MD, MHA, Medical Director, A.D.A.M. Health Solutions, Ebix, Inc.
A.D.A.M., Inc. is accredited by URAC, also known as the American Accreditation HealthCare Commission (www.urac.org). URAC's accreditation program is an independent audit to verify that A.D.A.M. follows rigorousstandards of quality and accountability. A.D.A.M. is among the first to achieve this important distinction for online health information andservices. Learn more about A.D.A.M.'s editorialpolicy, editorialprocess, and privacypolicy. A.D.A.M. is also a founding member of Hi-Ethics and subscribes to the principles of the Health on the Net Foundation (www.hon.ch.)
The information provided herein should not be used during any medical emergency or for the diagnosis or treatmentof any medical condition. A licensed medical professional should be consulted for diagnosis and treatment of any and all medical conditions.Call 911 for all medical emergencies. Links to other sites are provided for information only -- they do not constitute endorsements of those other sites. © 2014 A.D.A.M., Inc. Any duplication ordistribution of the information contained herein is strictly prohibited.